A Multimodal Imaging Study of Dopamine in Early Psychosis

Clinical trial NCT06977308 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06977308
Sponsor: New York State Psychiatric Institute
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical High Risk for Psychosis (CHR)

Start date: 2026-10-01
Primary completion: 2029-10-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.